IA
GNOM icon

IFP Advisors’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

IFP Advisors’s Portfolio GNOM Stock Details GNOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30.5K Buy
536
+37
+7% +$1.76K ﹤0.01% 2716
2026
Q1 		$21.8K Sell
499
-119
-19% -$5.5K ﹤0.01% 2729
2025
Q4 		$28.1K Sell
618
-2,217
-78% -$98.3K ﹤0.01% 2529
2025
Q3 		$42.8K Buy
2,835
+2,248
+383% +$81.4K ﹤0.01% 2161
2025
Q2 		$19.8K Sell
587
-18
-3% -$570 ﹤0.01% 2550
2025
Q1 		$19.2K Hold
605
– – ﹤0.01% 2298
2024
Q4 		$23.5K Sell
605
-163
-21% -$6.85K ﹤0.01% 2174
2024
Q3 		$34.5K Sell
768
-29
-4% -$1.3K ﹤0.01% 1892
2024
Q2 		$33.3K Hold
797
– – ﹤0.01% 1841
2024
Q1 		$36.3K Sell
797
-83
-9% -$3.78K ﹤0.01% 1707
2023
Q4 		$40.7K Hold
880
– – ﹤0.01% 1621
2023
Q3 		$35.8K Hold
880
– – ﹤0.01% 1696
2023
Q2 		$42.7K Buy
880
+482
+121% +$24.1K ﹤0.01% 1676
2023
Q1 		$23.9K Sell
398
-147
-27% -$7.57K ﹤0.01% 1939
2022
Q4 		$33K Sell
545
-35
-6% -$1.8K ﹤0.01% 2525
2022
Q3 		$35K Sell
580
-61
-10% -$3.44K ﹤0.01% 2648
2022
Q2 		$38K Hold
641
– – ﹤0.01% 2348
2022
Q1 		$38K Buy
641
+201
+46% +$12.7K ﹤0.01% 2348
2021
Q4 		$36K Sell
440
-438
-50% -$36.8K ﹤0.01% 1680
2021
Q3 		$78K Buy
878
+640
+269% +$60K ﹤0.01% 1399
2021
Q2 		$23K Buy
238
+63
+36% +$5.59K ﹤0.01% 1870
2021
Q1 		$15K Buy
175
+150
+600% +$14.8K ﹤0.01% 1965
2020
Q4 		$2K Hold
25
– – ﹤0.01% 2614
2020
Q3 		$2K Buy
+25
New +$1.79K ﹤0.01% 2478

Other funds holding GNOM

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
CFD
Creative Financial Designs Kokomo, Indiana $2.1B AUM 23.1% 1-Year Est. Return
SH
SLT Holdings Scottsdale, Arizona $160M AUM 52.3% 1-Year Est. Return
WMP
Wealth Management Partners Tucson, Arizona $425M AUM 60.71% 1-Year Est. Return
SWA
Sightline Wealth Advisors Groton, Connecticut $273M AUM 18.08% 1-Year Est. Return
Belvedere Trading
Belvedere Trading Chicago, Illinois $87.6B AUM 131.08% 1-Year Est. Return
AA
Armis Advisers Atlanta, Georgia $1.09B AUM 22.88% 1-Year Est. Return
GIA
Gladstone Institutional Advisory Palm Beach Gardens, Florida $3.16B AUM 29.04% 1-Year Est. Return
JWCA
J.W. Cole Advisors Tampa, Florida $5.83B AUM 32.38% 1-Year Est. Return
HHGA
Halbert Hargrove Global Advisors Long Beach, California $2.31B AUM 21.64% 1-Year Est. Return

IFP Advisors's GNOM Position: Q2 2026 in Review

IFP Advisors increased its Global X Genomics & Biotechnology ETF (GNOM) stake by 7.4% in Q2 2026, buying an estimated $1.76K and bringing the position to 536 shares worth $30.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2716.

IFP Advisors first reported a position in GNOM in Q3 2020 and has held it in 24 quarters since. The position peaked at $78K in Q3 2021. 17 funds tracked by Wall St. Rank hold GNOM as of Q2 2026.

  • IFP Advisors held 536 shares of Global X Genomics & Biotechnology ETF worth $30.5K as of Q2 2026.
  • IFP Advisors bought 37 Global X Genomics & Biotechnology ETF shares in Q2 2026, an estimated $1.76K.
  • Global X Genomics & Biotechnology ETF made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #2716 holding.
  • IFP Advisors first reported a position in Global X Genomics & Biotechnology ETF in Q3 2020 and has held it in 24 quarters since.
  • IFP Advisors's Global X Genomics & Biotechnology ETF position peaked at $78K in Q3 2021.
  • 17 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.